This module features case studies which highlight the role of nebivolol in the management of hypertensive patients with comorbidities such as high sympathetic overdrive, ischaemic heart disease, and atrial fibrillation, as well as in a hypertensive patient who demonstrated poor tolerability to ‘classical’ beta-blockers.
This Continuous Medical Education (CME) is supported by Menarini Singapore Ptd Ltd.
You must be a member to access this content.
To become a member, please register here.
If you're already a member, please sign in to access.